HYBRID EVENT:You can Participate either IN-PERSON or virtually through ZOOM from your home/work.
12th Edition of Global Insight Conference on
Breast Cancer (GICBC-2025)
Jul 07 - 08, 2025 at Vienna, Austria (Hybrid Event)
HYBRID EVENT:You can Participate either IN-PERSON or virtually through ZOOM from your home/work.
After the grand success of Eleven editions of breast cancer conferences, we solicit your gracious presence at the “12th Global Insight Conference on Breast Cancer" (GICBC-2025) which will be conducted during July 07-08, 2025 as a hybrid event at Vienna, Austria and virtually. The conference will emphasize the theme “Novel Discoveries in Breast Cancer Research & Treatment”.
Breast cancer represents a complicated family of diseases for which detection, diagnosis, and multimodal management strategies are continually evolving. With each lesson learned about the biology of these diseases, and with each improvement to the standards of care, new questions, challenges, and controversies arise.
The scientific programame varies from plenaries, symposia, interactive sessions, pre-congress workshops, joint symposia, poster sessions, and free paper presentations. Our guests will be invited to numerous lectures, meetings, poster presentations, and Exhibitors. We will also discuss organizational issues, with a particular focus on complex approaches for the treatment of Breast Cancer.
Innovinc International Conferences are powered by knowledge, experience, and amazing people and have managed to become one of the leading B2B event organizers. By gathering expert speakers and leading professionals and providing them with strategic knowledge and growth opportunities, our goal is to always focus on innovative trends, cover the most up-to-date topics, and work with top industry minds to prepare and execute high-quality premier events. Our mission is to organize conferences, publish high-quality conference proceedings, and provide services to scientists and young researchers on recent research updates in all fields.
The important benefits of attending this conference includes:
The organizing team of GICBC-2025 warmly welcomes you to join us in Vienna, Austria (Hybrid Event) on July 07-08, 2025. Do not hesitate and click the "Register" button on the top of the screen to register for attending the GICBC-2025.
Target Audience:
This conference is intended for medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, researchers, and other health care professionals interested in the treatment of breast cancer are also invited to attend.
Join us at GICBC-2025 to learn about the latest research updates in Breast Cancer field.
For further information, please feel free to contact me at breastcancer@innovinc.org or reach me Tel: +1-408-465-0048; WhatsApp number +1-408-352-1010
Warsaw Medical University, Poland
University of Cambridge, united kingdom
West China Hospital of Sichuan University, China
Karolinska Institutet, Sweden
Rush University Medical Center, USA
Holy Cross Health, USA
Medical University of Lodz, Poland
The University of Akron, USA
China Medical University Hospital, Taiwan
Baylor College of Medicine, USA
University of South Carolina, USA
The University of Texas MD Anderson Cancer Center, USA
Khoo Teck Puat Hospital, Singapor
Sichuan University, China
Lodz University of Technology, Poland
University of East Anglia, united kingdom
Rajiv Gandhi University of Health Sciences, India
Imam Mohammad Bin Saud Islamic University, Saudi Arabia
Meteorbiotech, South Korea
China Medical University Hospital, Taiwan
University of Arkansas for Medical Sciences, AR, USA
University of Texas at Houston, USA
Martin Luther University Halle-Wittenberg, Germany
Systems Immunology, Weizmannn Institute of Science, Israel
Academy of Scientific and Innovative Research, India
Predictoma, Inc., USA
Texas A & M University, USA
Peking University Third Hospital, China
National Research Institute, Poland
Azerbaijan Medical University, Azerbaijan
The University of Sydney, Camperdown, Australia
University of Torino, Italy
Michigan State University, USA
Nankai University, China
Aalen University, Germany
Guangyuan Central Hospital, China
National Institute of Biologicals, India
Punjabi University, India
HYD LLC for Cancer Research and Drug Development , Hungary
University of Palermo, Italy
OncoStem Diagnostics Pvt Ltd, India
Kangwon National University, South Korea
Abdullah AlSalem University, Kuwait
College of Medicine-University of Basra, Iraq
LEHMAN COLLEGE- City University of New York (CUNY), USA
Emory University School of Medicine, USA
Indian Institute of Science, India
Tufts University School of Medicine, USA
University of Miami-Miller School of Medicine, USA
Taipei City Hospital, Yangming Branch, Taipei, Taiwan
University of California, USA
Chung Shan Medical University Medical Clinical, Taiwan
Ankara University, Turkey
Stanford University School of Medicine, USA
AstraZeneca, USA
Sun Yat Sen University, China
University of Mississippi Medical Center, USA
The Sixth Affiliated Hospital of Sun Yat-sen University, China
Sun Yat-Sen University, China
Peking Union Medical College Hospital, China
University of Sriwijaya, Indonesia
University of Naples Federico, Italy
Inserm-Université Clermont-Auvergne, France
National Cancer Institute, USA
University College Dublin, Saudi Arabia
Don t Miss This Amazing Conference And Opportunities
This is a great academic conference, a wonderful experience, thank you for everything you have done. hope to see you next time,
It was really a fabulous experience, thanks to your guidance.
It was a very pleasurable and worthy experience.
It was a very interesting and powerful meeting.
The meeting was interesting and speeches were good.
It has been a pleasure to be part of this meeting.
Thank you so much for the opportunity to present. it was a great meeting.
Thank you very much for the great organization. It was a great organization for networking and starting new research collaborations. I will put next edition event on my calendar.